Clinical characteristics and risk factors for severe COVID-19 infections in Malaysia: A nationwide observational studyBenedict Lim Heng Sim, Pik Pin Goh, Suresh Kumar Chidambaram et al.|The Lancet Regional Health - Western Pacific|2020Cited by 132
Efficacy of Ivermectin Treatment on Disease Progression Among Adults With Mild to Moderate COVID-19 and ComorbiditiesSteven Lim, Sangeetha Jaya Selan, Hui Moon Koh et al.|JAMA Internal Medicine|2022Cited by 105
Efficacy of Early Treatment With Favipiravir on Disease Progression Among High-Risk Patients With Coronavirus Disease 2019 (COVID-19): A Randomized, Open-Label Clinical TrialChuan Huan Chuah, Bai Han Ooi, Ting Soo Chow et al.|Clinical Infectious Diseases|2021Cited by 47
Serology surveillance of SARS-CoV-2 antibodies among healthcare workers in COVID-19 designated facilities in MalaysiaYuan Liang Woon, Pik Pin Goh, Yee Leng Lee et al.|The Lancet Regional Health - Western Pacific|2021Cited by 23
Real-world nirmatrelvir-ritonavir outpatient treatment in reducing hospitalization for high-risk patients with COVID-19 during Omicron BA.4, BA.5 and XBB subvariants dominance in Malaysia: A retrospective cohort studyEe Vien Low, Kalaiarasu M. Peariasamy, Mohan Dass Pathmanathan et al.|International Journal of Infectious Diseases|2023Cited by 15